Transcription of latent and replicative Epstein-Barr-virus genes in bone-marrow and peripheral-blood mononuclear cells of health donors

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 524-529

  Gonnella, Roberta ^a   Angeloni, Antonio ^a   Calocero, Antonella ^b   Farina, Antonella ^a   Santarelli, Roberta ^a   Gentile, Giuseppe ^a   Arcese, William ^a   Martino, Pietro ^a   Mandelli, Franco ^a   Frati, Luigi ^a,b   Faggioni, Alberto ^a   Ragona, Giuseppe ^a,b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c Dipto di Medicina Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BONE MARROW CELL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS REPLICATION;

EID: 0030890822     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19970304)70:5<524::aid-ijc6>3.0.co;2-%23     Document Type: Article

References (33)

1. ALFIERI, C., TANNER, J., CARPENTIER, L., PERPETE, C., SAVOIE, A., PARADIS, K., DELAGE, G. and JONCAS, J., Epstein-Barr-virus transmission from a blood donor to an organ-transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood, 87, 812-817 (1996).
2. ANAGNOSTOPOULOS, I., HUMMEL, M., KRESCHEL, C. and STEIN H., Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr-virus-infectd cells in acute infectious mononucleosis: implications for the inter-individual infection route of Epstein-Barr virus. Blood, 85, 744-750 (1995).
3. BAER, B., BANKIER, A., BIGGIN, M.D., DEININGER, P., FARRELL, P.J., GIBSON, T., HUDSON, G., SATCHWELL, S., SEGUIN, C., TUFFNELL, P. and BARREL, B., DNA sequence and expression of the B-958 Epstein-Barr-virus genome. Nature (Lond), 310, 207-211 (1984).
4. CHEN, F., Zou, J.Z., DI RENZO, L., WINBERG, G., Hu, L.F., KLEIN, E., KLEIN, G. and ERNBERG, I., A sub-population of normal B cells latently infected with Epstein-Barr virus resembles Burkitt-lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1 J Virol., 69, 3752-3758 (1995).
5. DECKER, L.L., KLAMAN, L.D. and THORLHY-LAWSON, D.A., Detection of the latent form of Epstein-Barr-virus DNA in the peripheral blood of healthy individuals. J. Virol., 70, 3286-3289 (1996).
6. FARRELL, P., Epstein-Barr-virus genome. Advanc viral Oncol., 8, 103-144 (1989).
7. GOBLET, C., PROST, E., KATHYN, J. and WHALEN, G.R., One tube versus two-step amplification of RNA transcripts usine PCR. Methods Enzymol., 216, 160-168 (1992).
8. GRATAMA, J.W., OOSTERVEER, A.P., ZWAAN, F.E., LEPOUTRE, J., KLEIN, G. and ERNBERG, I., Eradication of Epstein-Barr virus by allogeneic bone-marrow transplantation. Implications for the sites of viral latency. Proc. nat. Acad. Sci. (Wash.), 85, 8693-8696 (1988).
9. KIEFF, E., Epstein-Barr virus - increasing evidence of a link to carcinoma. New Engl. J. Med., 333, 724-726 (1995).
10. KLEIN, G., Epstein-Barr-virus strategy in normal and neoplastic B cells. Cell, 77, 791-793 (1994).
11. LAM, K.M.C., WHITTLE, H., GRZYWACZ, M. and CRAWFORD, D.H., EpsteinBarr-virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients. Immunology, 82, 383-388 (1994).
12. MIYASHITA, E.M., YANG, B., LAM, K.M.C., CRAWFORD, D.H. and THORLEYLAWSON, D.A., A novel form of Epstein-Barr-virus latency in normal B cells in vivo. Cell, 80, 593-601 (1995).
13. NIEDOBITEK, G., AGATHANGGELOU, A., ROWE, M., JONES, E.L., TURYAGUMA, P., ORYEMA, J., WRIGHT, D.H. and YOUNG, L.S., Heterogeneous expression of Epstein-Barr-virus latent proteins in endemic Burkitt's lymphoma. Blood, 86, 659-665 (1995).
14. NIEDOBITEK, G., YOUNG, L.S., LAU, R., BROOKS, L., GREENSPAN, D., GREENSPAN, J.S. and RICKINSON, A.B., Epstein-Barr-virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J. gen. Virol., 72, 3035-3046 (1991).
15. NONKWELO, C., SKINNER, J., BELL, A., RICKINSON, A. and SAMPLE, J., Transcription start sites downstream of the Epstein-Barr-virus(EBV) Fp promoter in early-passage Burkitt-lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol., 70, 623-627 (1996).
16. OUDEJANS, J.J., JIWA, M., VAN DEN BRULE, A.J.C., GRASSER, F.A., HORSTMAN, A., Vos, W., KLUIN, P.M., VAN DER VALK, P., WALBOOMERS, J.M.M. and MEJER, C.J.L.M., Detection of heterogeneous Epstein-Barr-virus-geneexpression patterns within individual post-transplantation lymphoproliferative disorders. Amer. J. Pathol., 147, 923-933 (1995a).
17. OUDEJANS, J.J., VAN DEN BRULE, A.J.C., JIWA, N.M., DE BRUIN, P.C., OSSENKOPPELE, G.J., VAN DER VALK, P. WALBOOMERS, J.M.M. and MEIJER, C.J.L.M., BHRF1, the Epstein-Barr-virus(EBV) homologue of the BCL-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood, 86, 1893-1902 (1995b).
18. PAPADOPOULOS, E.B. and 12 OTHERS, Infusion of donor leukocytes to treat Epstein-Barr-virus-assoeiated lymphoproliferative disorders after allogeneic bone-marrow transplantation. New Engl. J. Med., 330, 1185-1191 (1994).
19. PATHMANATHAN, R., PRASAD, U., SADLER, R., FLYNN K. and RAAB-TRAUB, N., Clonal proliferations of cells infected with Epstein-Barr virus in pre-invasive lesions related to nusopharyngeal carcinoma. New Enql. J. Med., 333, 693-733 (1995).
20. QU, L. and ROWE, D., Epstein-Barr-virus latent gene expression in uncultured peripheral-blood lymphocytes. J. Virol., 66, 3715-3724 (1992).
21. RAGONA, G., TABILIO, A., FRUSCALZO, A., ANNINO, L., ANGELONI, A. and BERTOLINI, L., Presence of EBV-infected cells in the bone marrow from transplant donors. In: D.V. Ablashi, A. Faggioni, G.R.F. Krueger, J.S. Pagano and G.R. Pearson (eds), Epstein-Barr virus and human disease., pp. 231-237. Humana Press. Clifton, NJ (1989).
22. ROCCHI, G., DE FELICI, A., RAGONA. G. and HEINZ, A., Quantitative evaluation of Epstein-Barr-virus-infected peripheral-blood leukocytes in infectious mononucleosis. New Engl. J. Med., 296, 132-137 (1977).
23. ROONEY, C.M., SMITH, C.A., NG, C.Y., LOFTIN, S., LI, C., KRANCE, R.A., BRENNER, M.K. and HELSOP, H.E., Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet, 345, 9-13 (1995).
24. ROWE, M., YOUNG, L.S., CROCKER, J., STOKES. H., HENDERSON, S. and RICKINSON, A.B., Epstein-Barr-virus(EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. exp. Med., 173, 147-158 (1991).
25. ROWE, M., LEAR, A.L., CROOM-CARTER, D., DAVIES, A.H. and RICKINSON, A.B., Three pathways of Epstein-Barr-virus-gene activation from EBNA-11 positive latency in B lymphocytes. J. Virol., 66, 122-131 (1992).
26. SAMBROOK, J., FRITSCH, E.T. and MANIATIS, T., Molecular cloning, Cold Spring Harbor Laboratory, New York (1989).
27. SAMPLE, J. and KIEFF, E., Transcription of the Epstein-Barr-virus genome during latency in growth-transformed lymphocytes. J. Virol., 64, 1667-1674 (1990).
28. SCHAEFER, B.C., STROMINGER, J.L. and SPECK, S.H., Redefining the Epstein-Barr-virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group-I Burkitt-lymphoma cell lines. Proc. nat. Acad. Sci. (Wash.), 92, 10565-10569 (1995a).
29. SCHAEFER, B.C., STROMINGER, J.L. and SPECK. S.H., The Epstein-Barr-virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA-1-gene transcription in group-I Burkitt's-lymphoma cell lines. J. Virol., 69, 5039-5047 (1995b).
30. SHAPIRO, R.S. and 12 OTHERS, Epstein-Barr-virus-associated B-cell lymphoproliferative disorders following bone-marrow transplantation. Blood, 71, 1234-1243 (1988).
31. TAO, Q., SRIVASTAVA, G., CHAN, A.C., CHUNG, L.P., LOKE, S.L. and HO, F.C., Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cell in normal individuals. J. med. Virol., 45, 71-77 (1995).
32. TAYLOR, K.A., WETZEL. S., LYLES, D.S. and POLLOK, B.A., Dual EBNA-1promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. J. Virol., 68, 6421-6431 (1994).
33. TIERNEY, R.J., STEVEN, N., YOUNG. L.S. and RICKINSON, A.B., Epstein-Barrvirus latency in blood mononuelear cells: analysis of viral-gene transcription during the primary infection and in the carrier state. J. Virol., 68, 7374-7385. (1994).